chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal stiffness, Neck pain, Pain, Paraesthesia, Skin warm
Clinical narrative: Information has been received from a registered nurse concerning a 62 year old patient who on 20-JAN-2009 was vaccinated with ZOSTER vaccine live (Oka/Merck) (Lot # not reported).  On 21-JAN-2009, the patient had a reaction.  The nurse stated the patient reported a welt that was hot, bright red and very sensitive.  The nurse stated the welt was still present in addition to neck pain that "feels like an electrical impulse".  The patient currently had a "golf ball size bump that is purple, red and painful to touch."  The patient was being treated with ibuprofen.  The patient was not recovered from the adverse events.  It was not reported whether the patients sought medical attention.  Additional information has been received from the licensed practical nurse concerning the now 63 year old patient with allergy to CODEINE, SAR, DAR, ROAD, and a history of cervical cancer in 1980, hepatitis in 1965 and osteopenia who on 20-JAN-2009 3:00 PM was vaccinated SQ with the first dose of ZOSTER vaccine live (Oka/Merck) (Lot # 662757/1622X) in her right arm.  On 21-Jan-2009 9:00 AM, the patient had reaction.  On 26-JAN-2009, the patient's swelling was 5-6 inches long, hot, bright red in middle and faded red around edges, and felt electrical impulse.  Dr.'s recommendation: Call if sighs and symptoms continued.  We would being down swelling with PREDNISONE, but would compromise effectiveness of vaccine.  On 30-JAN-2009, the patient called reaction still very sensitive, stiff neck, shooting pain down her shoulder blade right side arm.  Reaction was getting no better per patient.  Dr recommendation: office visit now, ibuprofen 200mg, 1-2 tabs BID.  Upon observation on 30-JAN-2009, the area on right arm golf ball size red was vague discomfort, the patient's arm was feeling funny with extension and adduction, and hurt to turn head.  On 5-FEB-2009, the patient stated reaction to ZOSTER vaccine live (Oka/Merck) was almost gone, but still had a "strange feeling" in upper back / neck but discomfort diminishing.  On 17-FEB-2009, the patient still got pain when changed position at night, or walked too hard on heels. "Feels strange" in neck arm large local reaction was now gone.  The patient was not completely recovered from adverse events.  No further information is available.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Swelling, Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 62 year old patient who on 20-JAN-2009 was vaccinated with ZOSTER vaccine live (Oka/Merck) (Lot # not reported).  On 21-JAN-2009, the patient had a reaction.  The nurse stated the patient reported a welt that was hot, bright red and very sensitive.  The nurse stated the welt was still present in addition to neck pain that "feels like an electrical impulse".  The patient currently had a "golf ball size bump that is purple, red and painful to touch."  The patient was being treated with ibuprofen.  The patient was not recovered from the adverse events.  It was not reported whether the patients sought medical attention.  Additional information has been received from the licensed practical nurse concerning the now 63 year old patient with allergy to CODEINE, SAR, DAR, ROAD, and a history of cervical cancer in 1980, hepatitis in 1965 and osteopenia who on 20-JAN-2009 3:00 PM was vaccinated SQ with the first dose of ZOSTER vaccine live (Oka/Merck) (Lot # 662757/1622X) in her right arm.  On 21-Jan-2009 9:00 AM, the patient had reaction.  On 26-JAN-2009, the patient's swelling was 5-6 inches long, hot, bright red in middle and faded red around edges, and felt electrical impulse.  Dr.'s recommendation: Call if sighs and symptoms continued.  We would being down swelling with PREDNISONE, but would compromise effectiveness of vaccine.  On 30-JAN-2009, the patient called reaction still very sensitive, stiff neck, shooting pain down her shoulder blade right side arm.  Reaction was getting no better per patient.  Dr recommendation: office visit now, ibuprofen 200mg, 1-2 tabs BID.  Upon observation on 30-JAN-2009, the area on right arm golf ball size red was vague discomfort, the patient's arm was feeling funny with extension and adduction, and hurt to turn head.  On 5-FEB-2009, the patient stated reaction to ZOSTER vaccine live (Oka/Merck) was almost gone, but still had a "strange feeling" in upper back / neck but discomfort diminishing.  On 17-FEB-2009, the patient still got pain when changed position at night, or walked too hard on heels. "Feels strange" in neck arm large local reaction was now gone.  The patient was not completely recovered from adverse events.  No further information is available.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Local reaction, Oedema peripheral, Pruritus
Clinical narrative: Information has been received from a certified medical assistant concerning a 62 year old male patient with no known drug reactions/allergies with gastrooesophageal reflux, diverticulitis, sleep apnoea, depression, hyperlipidaemia, arthritis and diabetes who on 20-JAN-2009 was vaccinated subcutaneously into the right arm with a 0.65ml dose of with ZOSTER vaccine live (Oka/Merck) (Lot #663196/1417X).  Concomitant therapy included CARDURA, CIALIS, DEPAKOTE, DETROL LA, METFORMIN, NABUMETONE, NEXIUM, SIMVASTATIN MSD and ZOLOFT.  The medical assistant reported that after vaccination (on unspecified date) the patient experienced a localized red, raised area with slight itching on the right arm.  The area was the size of a "plum".  The patient was told to apply a cold compress, take ibuprofen 3 tablet 3 times a day, and to call if any question or worsening of symptoms.  The patient sought medical attention by phone on 23-JAN-2009.  Additional information has been requested.  This is one of two cases from the same source.  This is a consolidation of two reports concerning the same patient.  Additional information has been requested.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Biopsy skin normal, Culture negative, Dermatitis, Herpes zoster, Pruritus
Clinical narrative: Information has been received from a pharmacist and a medical assistant concerning an 81 year old female who on 08-DEC-2008 was vaccinated subcutaneously with a dose of ZOSTER vaccine live (Oka/Merck) (lot # 663196/1417X).  Concomitant therapy included NORVASC, HYDROCHLOROTHIAZIDE (unspecified), LEVOTHYROXINE SODIUM and LOSARTAN POTASSIUM (MSD).  It was reported that the patient complained of severe itching on her back and she had small lesions on the one side of her back that look like bites started from 25-JAN-2009 to 26-JAN-2009.  It was reported that the patient developed shingles rash.  The patient was recommended to see a dermatologist.  The dermatologist had prescribed a steroid cream and FLUOCINONIDE on 27-JAN-2009, VALTREX on 28-JAN-2009, and BACTROBAN on either 27-JAN-2009 or 30-JAN-2009 to treat the patient's symptoms.  The patient's shingles rash persisted.  As of 02-FEB-2009, the patient was not recovered.  Follow-up information was received which reported that the patient's drug allergies included CODEINE, CORTISONE and PENICILLIN.  The patient was enrolled in the VARICELLA ZOSTER Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the Oka/Merck vaccine VZV strain.  The sample of the lesion was collected on 28-JAN-2009.  The sample was taken from a punch excision of skin on the left posterior shoulder.  The findings are suggestive of toxic dermatitis.  The possibility of a drug eruption could be considered, if the clinical picture allows.  The PCR results for the specimen from a punch excision of skin on the left posterior shoulder was negative.  Additional information has been requested. 06/24/09 This is in follow-up to report(s) previously submitted on 3/27/2009. Follow-up information was received which reported that the patient presented on 28-JAN-2009 with a rash on the left shoulder, papulovesicles in a linear distribution. Culture taken was negative. On 02-FEB-2009 a biopsy was performed, results were drug eruption. The patient treated with BACTROBAN and ELOCON compound. Additional information has been requested.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Skin lesion, Varicella zoster serology negative
Clinical narrative: Information has been received from a pharmacist and a medical assistant concerning an 81 year old female who on 08-DEC-2008 was vaccinated subcutaneously with a dose of ZOSTER vaccine live (Oka/Merck) (lot # 663196/1417X).  Concomitant therapy included NORVASC, HYDROCHLOROTHIAZIDE (unspecified), LEVOTHYROXINE SODIUM and LOSARTAN POTASSIUM (MSD).  It was reported that the patient complained of severe itching on her back and she had small lesions on the one side of her back that look like bites started from 25-JAN-2009 to 26-JAN-2009.  It was reported that the patient developed shingles rash.  The patient was recommended to see a dermatologist.  The dermatologist had prescribed a steroid cream and FLUOCINONIDE on 27-JAN-2009, VALTREX on 28-JAN-2009, and BACTROBAN on either 27-JAN-2009 or 30-JAN-2009 to treat the patient's symptoms.  The patient's shingles rash persisted.  As of 02-FEB-2009, the patient was not recovered.  Follow-up information was received which reported that the patient's drug allergies included CODEINE, CORTISONE and PENICILLIN.  The patient was enrolled in the VARICELLA ZOSTER Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the Oka/Merck vaccine VZV strain.  The sample of the lesion was collected on 28-JAN-2009.  The sample was taken from a punch excision of skin on the left posterior shoulder.  The findings are suggestive of toxic dermatitis.  The possibility of a drug eruption could be considered, if the clinical picture allows.  The PCR results for the specimen from a punch excision of skin on the left posterior shoulder was negative.  Additional information has been requested. 06/24/09 This is in follow-up to report(s) previously submitted on 3/27/2009. Follow-up information was received which reported that the patient presented on 28-JAN-2009 with a rash on the left shoulder, papulovesicles in a linear distribution. Culture taken was negative. On 02-FEB-2009 a biopsy was performed, results were drug eruption. The patient treated with BACTROBAN and ELOCON compound. Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Diarrhoea, Fatigue, Flushing, Headache
Clinical narrative: Information has been received from a nurse practitioner concerning a 68 year old female with hypertension, arthritis and a history of genital herpes.  The patient is allergic to DARVON, FORMALDEHYDE, AVELOX, ZITHROMAX, eggs and chicken.  The patient took VALTREX 500mg once daily for 10 years but discontinued in September 2008.  On 16-JAN-2009 the patient was vaccinated with her first dose of ZOSTER vaccine live (Oka/Merck) (lot number 663638/1706X) SQ into her left arm.  Concomitant therapy included DIOVAN, AMBIEN.  On 27-JAN-2009 the patient developed shingles after vaccination.  The patient was experiencing pain, blurred vision, low-grade fever, flushing and fatigue.  The pruritic erythematous blister-like lesions were across her left eye towards her ear and forehead.  The patient had 4 rows of blisters about 4 to 8 blisters per row.  The patient was prescribed VALTREX.  After starting VALTREX the patient developed diarrhea and headaches.  VARICELLA titer was performed with no results reported.  Follow-up information was received from the nurse.  Then nurse reported that the patient developed shingles on her left face and across her left eye.  The patient was sent to ophthalmologist.  The patient was given VALTREX.  The patient complained of burning and pain at site.  The patient was seen by ophthalmologist twice.  There was no illness at time of vaccination.  The patient's outcome was unknown.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 03/27/09. Follow-up information was received from the nurse. On 23-FEB-2009 and 23-MAR-2009 the patient had two visits for post herpetic neuralgia. On 23-MAR-2009 the patient had another outbreak on her face (same location). There was no illness at time of vaccination. The patient's outcome was unknown. No further information was available.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Injection site irritation, Injection site pain, Pain, Pyrexia
Clinical narrative: Information has been received from a nurse practitioner concerning a 68 year old female with hypertension, arthritis and a history of genital herpes.  The patient is allergic to DARVON, FORMALDEHYDE, AVELOX, ZITHROMAX, eggs and chicken.  The patient took VALTREX 500mg once daily for 10 years but discontinued in September 2008.  On 16-JAN-2009 the patient was vaccinated with her first dose of ZOSTER vaccine live (Oka/Merck) (lot number 663638/1706X) SQ into her left arm.  Concomitant therapy included DIOVAN, AMBIEN.  On 27-JAN-2009 the patient developed shingles after vaccination.  The patient was experiencing pain, blurred vision, low-grade fever, flushing and fatigue.  The pruritic erythematous blister-like lesions were across her left eye towards her ear and forehead.  The patient had 4 rows of blisters about 4 to 8 blisters per row.  The patient was prescribed VALTREX.  After starting VALTREX the patient developed diarrhea and headaches.  VARICELLA titer was performed with no results reported.  Follow-up information was received from the nurse.  Then nurse reported that the patient developed shingles on her left face and across her left eye.  The patient was sent to ophthalmologist.  The patient was given VALTREX.  The patient complained of burning and pain at site.  The patient was seen by ophthalmologist twice.  There was no illness at time of vaccination.  The patient's outcome was unknown.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 03/27/09. Follow-up information was received from the nurse. On 23-FEB-2009 and 23-MAR-2009 the patient had two visits for post herpetic neuralgia. On 23-MAR-2009 the patient had another outbreak on her face (same location). There was no illness at time of vaccination. The patient's outcome was unknown. No further information was available.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pruritic, Skin lesion, Vision blurred
Clinical narrative: Information has been received from a nurse practitioner concerning a 68 year old female with hypertension, arthritis and a history of genital herpes.  The patient is allergic to DARVON, FORMALDEHYDE, AVELOX, ZITHROMAX, eggs and chicken.  The patient took VALTREX 500mg once daily for 10 years but discontinued in September 2008.  On 16-JAN-2009 the patient was vaccinated with her first dose of ZOSTER vaccine live (Oka/Merck) (lot number 663638/1706X) SQ into her left arm.  Concomitant therapy included DIOVAN, AMBIEN.  On 27-JAN-2009 the patient developed shingles after vaccination.  The patient was experiencing pain, blurred vision, low-grade fever, flushing and fatigue.  The pruritic erythematous blister-like lesions were across her left eye towards her ear and forehead.  The patient had 4 rows of blisters about 4 to 8 blisters per row.  The patient was prescribed VALTREX.  After starting VALTREX the patient developed diarrhea and headaches.  VARICELLA titer was performed with no results reported.  Follow-up information was received from the nurse.  Then nurse reported that the patient developed shingles on her left face and across her left eye.  The patient was sent to ophthalmologist.  The patient was given VALTREX.  The patient complained of burning and pain at site.  The patient was seen by ophthalmologist twice.  There was no illness at time of vaccination.  The patient's outcome was unknown.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 03/27/09. Follow-up information was received from the nurse. On 23-FEB-2009 and 23-MAR-2009 the patient had two visits for post herpetic neuralgia. On 23-MAR-2009 the patient had another outbreak on her face (same location). There was no illness at time of vaccination. The patient's outcome was unknown. No further information was available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Post herpetic neuralgia
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with ZOSTER vaccine live (Oka/Merck) 0.65ml (lot number, route and site not reported).  After vaccination, the patient experienced shingles.  Follow up information was received from HERPES ZOSTER Questionnaire.  On 10-MAR-2008 the patient with a history of chickenpox was vaccinated with ZOSTER vaccine live (Oka/Merck) (lot number 659325/1823U) into the right arm.  There was no rash at the site of injection or elsewhere within 42 days of the vaccination.  On 09-JAN-2009 the patient developed HERPES ZOSTER.  The pain was at least at grade 5.  There was no fever and other systemic symptoms.  There was no recent exposure to chickenpox or HERPES ZOSTER.  A direct fluorescent antibody was not done and specimen was not collected for polymerase chain reaction (PCR).  There was no photo taken.  The patient's HERPES ZOSTER recovered.  The patient is still having post herpetic neuralgia.  This is one of several reports received from the same source.  Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site pruritus, Injection site urticaria, Injection site warmth
Clinical narrative: Information has been received from a pharmacist concerning a 62 year old female with allergic reaction to TETRACYCLINE and PHENOBARBITAL who on 30-JAN-2009 was vaccinated with ZOSTER vaccine live (Oka/Merck) (lot number 662971/1213X) 0.65ml SQ (site not reported).  Concomitant therapy included METHADONE HC1 and DICYCLOMINE HC1.  On 01-FEB-2009 the patient developed a welt at the injection site that is about 3cm in diameter.  On 02-FEB-2009 the injection site was itchy.  The patient's welt at the injection site and itchy persisted.  The patient's adverse events persist.  Additional information was received from the consumer concerning her self.  The patient reported that on 31-JAN-2009 she noticed that that site was painful and warm to the touch and raised (welt about 3 inches in diameter).  Additional information has been requested.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Palpitations
Clinical narrative: Information has been received from a licensed practical nurse concerning a 78 year old female with hypertension, hyperlipidaemia and a history of palpitations who on 25-FEB-2008 was vaccinated with ZOSTER vaccine live (Oka/Merck) (lot number 658208/0886U) 0.65ml subcutaneous (site not reported).  On 26-JAN-2009 the patient developed a very mild case of shingles on her head.  The patient was seen in the office.  The patient's shingles was recovering.  Additional information has been requested.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Feeling abnormal, Herpes zoster, Rash, Rash vesicular, Secondary transmission
Clinical narrative: Information has been received from a physician concerning a 67 year old male with colitis ulcerative, gout and metabolic syndrome whose wife was vaccinated with ZOSTAVAX (Merck).  The physician believed that ZOSTAVAX had been transmitted from a vaccinee to a susceptible contact causing shingles.  The patient's concomitant therapy included balsalazide disodium (manufacture unknown), OMEPRAZOLE (manufacture unknown), and  PAROXETINE (manufacture unknown).  The patient's wife was vaccinated with ZOSTAVAX (Merck) (LOT# not reported) on 19-JAN-2009.  The patient started to feel "funny" approximately one week ago, then rash appeared 3 days ago.  The rash appeared near his right forehead and eye.  The wife had no symptoms.  The patient was not recovered from the adverse events.  It was reported that the patient sought medical attention:  saw the physician.  Additional information has been requested. 06/24/09 This is in follow-up to report(s) previosly submitted on 3/27/2009. Follow-up information was received from the physician which reported that the male patient also had GERD, allergic rhinitis and spondylolisthesis. The information about vaccination was unknown because the vaccine was given by the wife's physician to the patient's wife on 19-JAN-2009. The patient developed atypical zoster like rash and outbreak of shingles on the face on 31-JAN-2009. The patient was seen in the eye clinic on 21-FEB-2009. The patient's experiences had been treated (treatment not specified). The outcome of shingles was unknown. The relevant diagnostic test and laboratory was reported as NA. Additional information has been requested.
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a certified medical assistant concerning a 76 year old male with hypertension and coronary artery disease who on 26-JAN-2009 was vaccinated with ZOSTAVAX (Merck) (lot number 663178/1414X, route and site not reported).  On 03-FEB-2009 the patient was diagnosed with shingles on her leg and hip.  Additional information has been requested. This is in follow-up to report (s) previouly submitted on 3/27/2009.  Information had been received from a certified medical assistant concerning a 76 year old male with hypertension and coronary artery disease who on 26-JAN-2009 was vaccinated with ZOSTAVAX (Merck) (lot number 663178/1414X, route and site not reported).  On 03-FEB-2009 the patient was diagnosed with shingles on his leg and hip.  Follow up information was received from the medical assistant.  On 26-JAN-2009 the Caucasian patient was vaccinated with the first dose of ZOSTAVAX (lot number 663178/1414X) SQ into his left arm.  On 31-JAN-2009 the patient developed acute zoster.  The patient was treated with VALTREX and AMITHIPTYLIN.  The patient recovered.  It was unspecified if there was illness at time of vaccination.  Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Hyperhidrosis, Pyrexia
Clinical narrative: Information has been received from a pharmacist concerning a 66 year old female with allergic reaction to antibiotics who at "some time last week" was vaccinated with one dose of ZOSTER vaccine live (Oka/Merck) (lot number 663673/1710X) SQ (site not reported).  There was no concomitant medication.  Three to four days after the vaccination, the patient developed a fever and sweating episodes.  Subsequently, the patient recovered from fever and sweating episode.  Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Herpes zoster
Clinical narrative: Information has been received from a female who on 23-JAN-2009 was vaccinated with ZOSTER vaccine live (Oka/Merck) (lot number, route and site not reported).  Concomitant therapy included ALVESCO.  On 31-JAN-2009 the patient had a burning sensation in the middle of her back that extends around in a ban pattern at her bra line.  The patient called her physician and was diagnose with shingles over the phone.  The physician told her to come in for an office visit if she developed a rash.  No rash at the time of this report.  The patient reported that the burning sensation improved when she stopped using her ALVESCO inhaler.  Additional information has been requested.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Swelling
Clinical narrative: Information has been received from a 64 year old female with no medical history and no drug allergies who on 29-JAN-2009 was vaccinated with a 0.65 ml dose of ZOSTER vaccine live (Oka/Merck) (lot # 662997/1619X).  Concomitant therapy included FLOVENT, vitamins (unspecified) and hormones (unspecified).  On 31-JAN-2009 the patient experienced swelling and redness after the vaccination.  The patient sought medical attention.  No lab tests performed.  As of 03-FEB-2009, the patient had not recovered.  Additional information is not expected.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Antinuclear antibody negative, Aspartate aminotransferase normal, Blood albumin decreased, Blood calcium decreased, Blood creatine phosphokinase increased
Clinical narrative: Information has been received from a physician concerning a 60 year old female with hypothyroidism, hyperlipidaemia, sciatica and back problems who on 15-JAN-2009 was vaccinated with ZOSTER vaccine live (Oka/Merck) (Lot # not reported).  After receiving ZOSTER vaccine live (Oka/Merck), the patient began to experience myalgia and elevated CPK levels.  The patient went to her chiropractor (who had previously been treating her for sciatica and back problems) then referred to a rheumatologist who ordered blood tests.  She went back to her primary physician for her symptoms.  On 30-JAN-2009, the patient had myalgia and nausea that was better with rest and worsens with activity.  At the time she developed the significant body aches and her CPK level was over 1000.  The patient had been stable on an unspecified statin for a long time with no problems.  The statin was recently discontinued due to the CPK.  There was no improvement in patient's condition.  It was reported that the patient sought medical attention.  Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: C-reactive protein increased, Coagulation test normal, Laboratory test normal, Myalgia, Nausea
Clinical narrative: Information has been received from a physician concerning a 60 year old female with hypothyroidism, hyperlipidaemia, sciatica and back problems who on 15-JAN-2009 was vaccinated with ZOSTER vaccine live (Oka/Merck) (Lot # not reported).  After receiving ZOSTER vaccine live (Oka/Merck), the patient began to experience myalgia and elevated CPK levels.  The patient went to her chiropractor (who had previously been treating her for sciatica and back problems) then referred to a rheumatologist who ordered blood tests.  She went back to her primary physician for her symptoms.  On 30-JAN-2009, the patient had myalgia and nausea that was better with rest and worsens with activity.  At the time she developed the significant body aches and her CPK level was over 1000.  The patient had been stable on an unspecified statin for a long time with no problems.  The statin was recently discontinued due to the CPK.  There was no improvement in patient's condition.  It was reported that the patient sought medical attention.  Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Red blood cell sedimentation rate normal, Rheumatoid factor negative
Clinical narrative: Information has been received from a physician concerning a 60 year old female with hypothyroidism, hyperlipidaemia, sciatica and back problems who on 15-JAN-2009 was vaccinated with ZOSTER vaccine live (Oka/Merck) (Lot # not reported).  After receiving ZOSTER vaccine live (Oka/Merck), the patient began to experience myalgia and elevated CPK levels.  The patient went to her chiropractor (who had previously been treating her for sciatica and back problems) then referred to a rheumatologist who ordered blood tests.  She went back to her primary physician for her symptoms.  On 30-JAN-2009, the patient had myalgia and nausea that was better with rest and worsens with activity.  At the time she developed the significant body aches and her CPK level was over 1000.  The patient had been stable on an unspecified statin for a long time with no problems.  The statin was recently discontinued due to the CPK.  There was no improvement in patient's condition.  It was reported that the patient sought medical attention.  Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: HEPA, MMR, PPV, VARCEL, VARZOS
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 14 month old female with no relevant medical history or past drug history who on 03-FEB-2009 was accidentally vaccinated intramuscularly with a 0.05 ml dose of ZOSTER vaccine live (Oka/Merck) (lot # 663199/1551X).  Concomitant therapy included MMR II , PREVNAR and VAQTA(manufacturer unknown) were given on 03-FEB-09.  On 03-FEB-2009 the patient experienced inappropriate schedule of vaccine administered.  It is unknown if there is any relevant laboratory data.  It is unknown if the patient had experienced any adverse effects.  Follow-up information was received from the R.N. which reported that the intended dose was VARIVAX (Oka/Merck) (MSD).  It was confirmed that the patient was given a dose of ZOSTER vaccine live (Oka/Merck), and VARIVAX (Oka/Merck) (MSD) was not administered after ZOSTER vaccine live (Oka/Merck).  It was reported that this was an error in the office and since then both vaccines are now stored in separate locations to avoid future confusion.  Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a pharmacist concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (lot number, injection site and route not reported).  Subsequently the patient experienced shingles like symptoms for 48 hours.  The pharmacist reported that the patient had received "6 chickenpox vaccines in the 1970's".  The pharmacist did not have information on this patient but remember "spent a significant time on this case".  The outcome of the patient's experience was unknown.  This is one of several reports received from the same source.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/27/2009.  Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Blister, Headache, Herpes zoster, Nausea
Clinical narrative: Information has been received from a 66 year old female patient with penicillin allergy, no pertinent medical history, who on 23-JAN-2009 was vaccinated with a dose of ZOSTAVAX (Oka/Merck).  Concomitant therapy included LIPITOR and COUMADIN and blood pressure medication (unspecified).  On approximately 30-JAN-2009, the patient experienced shingles on her face.  The blisters were on her temple, eye, scalp and a little bit on her lip.  The patient also experienced nausea, stomach problems, headache, and fever.  The patient did have some tingling sensation but did not experience any nerve pain where the blisters appeared.  She had to go to an eye doctor who told her it was shingles.  There were no laboratory or diagnostic tests performed.  At the time of reporting, the patient had not recovered.  Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Paraesthesia, Pyrexia
Clinical narrative: Information has been received from a 66 year old female patient with penicillin allergy, no pertinent medical history, who on 23-JAN-2009 was vaccinated with a dose of ZOSTAVAX (Oka/Merck).  Concomitant therapy included LIPITOR and COUMADIN and blood pressure medication (unspecified).  On approximately 30-JAN-2009, the patient experienced shingles on her face.  The blisters were on her temple, eye, scalp and a little bit on her lip.  The patient also experienced nausea, stomach problems, headache, and fever.  The patient did have some tingling sensation but did not experience any nerve pain where the blisters appeared.  She had to go to an eye doctor who told her it was shingles.  There were no laboratory or diagnostic tests performed.  At the time of reporting, the patient had not recovered.  Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Hypoaesthesia, Pain, Rash
Clinical narrative: Information has been received from a 70 year old female patient with blood pressure high, no drug reactions / allergies, who on 13-JAN-2009 was vaccinated with a dose of ZOSTER vaccine live (Oka/Merck).  The patient was on other medications but did not mention what medications they were on.  On 30-JAN-2009 the patient went to her physician's office and was diagnosed with the shingles.  The patient reports that she had the shingles on the front and back of her right tip.  The patient's physician gave her VALTREX, LYRICA and VICODIN to help with a rash, numbness and pain she was having with the shingles.  There were no laboratory or diagnostic tests performed.  At the time of reporting, the patient had not recovered.  Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Biopsy site unspecified normal, Hypersensitivity, Laboratory test, Pain, Proctalgia
Clinical narrative: Information has been received from a 66 year old female consumer with no known drug reactions/allergies and breast cancer since January 2007, who on 11-MAY-2008 was vaccinated with a dose of ZOSTER vaccine live (Oka/Merck).  Concomitant medication included thyroid medication.  In August 2008, the patient started to have a rash with "fluid filled pustules from head to toe that burn and feel like someone was stabbing me with a needle".  The patient stated that she had sores in her mouth and had burning pain in her vaginal and rectal area.  The patient reported that so far she had gone to see four dermatologists and a gynecologist regarding the rash.  The firs dermatologist gave her PREDNISONE (manufacturer unspecified) for three weeks and the second dermatologist put her on Z pack (manufacturer unspecified).  The other prescription creams (names and manufacturers unspecified).  The patient went to see her gynecologist for the burning pain she was having in her rectal and vaginal area and was given more topical creams (names and manufacturers unspecified).  The patient stated that her oncologist the referred her to two other dermatologists.  The dermatologists did some blood test, which all came back fine, and a biopsy with was negative. The patient stated that all the physicians were stating that she appeared to be having an allergic reaction to the vaccine.  The patient still had the rash, she was homebound and in constant pain.  The patient received a small pox vaccine (name and manufacturer unspecified may) many years ago and her arm blew up to the size of a thigh and she had weeping pustules on her arms that lasted for the summer through the winter.  The specific date this happened was not mentioned.  In follow-up the patient's husband stated that his wife had a history of cancer.  And that it had been over a year since she had had any cancer treatments.  At the time of reporting the patient was not recovered.  Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pustular, Stomatitis, Vulvovaginal pain
Clinical narrative: Information has been received from a 66 year old female consumer with no known drug reactions/allergies and breast cancer since January 2007, who on 11-MAY-2008 was vaccinated with a dose of ZOSTER vaccine live (Oka/Merck).  Concomitant medication included thyroid medication.  In August 2008, the patient started to have a rash with "fluid filled pustules from head to toe that burn and feel like someone was stabbing me with a needle".  The patient stated that she had sores in her mouth and had burning pain in her vaginal and rectal area.  The patient reported that so far she had gone to see four dermatologists and a gynecologist regarding the rash.  The firs dermatologist gave her PREDNISONE (manufacturer unspecified) for three weeks and the second dermatologist put her on Z pack (manufacturer unspecified).  The other prescription creams (names and manufacturers unspecified).  The patient went to see her gynecologist for the burning pain she was having in her rectal and vaginal area and was given more topical creams (names and manufacturers unspecified).  The patient stated that her oncologist the referred her to two other dermatologists.  The dermatologists did some blood test, which all came back fine, and a biopsy with was negative. The patient stated that all the physicians were stating that she appeared to be having an allergic reaction to the vaccine.  The patient still had the rash, she was homebound and in constant pain.  The patient received a small pox vaccine (name and manufacturer unspecified may) many years ago and her arm blew up to the size of a thigh and she had weeping pustules on her arms that lasted for the summer through the winter.  The specific date this happened was not mentioned.  In follow-up the patient's husband stated that his wife had a history of cancer.  And that it had been over a year since she had had any cancer treatments.  At the time of reporting the patient was not recovered.  Additional information has been requested.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Aphthous stomatitis, Fatigue, Full blood count normal, Lymphadenopathy, Mouth ulceration
Clinical narrative: Information has been received from a medical assistant concerning a 63 year old male with diabetes and no drug allergies who on 15-NOV-2008 was vaccinated SQ into the left arm with a dose of ZOSTAVAX (Oka/Merck) (663197/1418X).  It was reported that the patient was on a diabetic diet.  On 30-JAN-2009 the patient experienced fever of 104.2 F, fatigue, body aches, swollen cervical lymph nodes and oral ulceration's.  The patient sought medical attention at physician's office.  The patient was examined and prescribed AUGMENTIN.  A rapid strep test was negative and a complete blood count was normal.  The patient was examined again on 04-FEB-2009 and the symptoms were improved.  As of 05-FEB-2009, the patient was recovering.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/27/2009.  Follow-up information was received from the medical assistant.  It was reported that the 63 year old white male patient developed a viral syndrome including severe aphthous ulcers in the mouth not long after the vaccination OF zoster vaccine live (Oka/Merck).  The reporter stated that "there is no connection between the two".  At the time of the report, the patient recovered.  No further information is available.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Pyrexia, Streptococcal identification test, Viral infection
Clinical narrative: Information has been received from a medical assistant concerning a 63 year old male with diabetes and no drug allergies who on 15-NOV-2008 was vaccinated SQ into the left arm with a dose of ZOSTAVAX (Oka/Merck) (663197/1418X).  It was reported that the patient was on a diabetic diet.  On 30-JAN-2009 the patient experienced fever of 104.2 F, fatigue, body aches, swollen cervical lymph nodes and oral ulceration's.  The patient sought medical attention at physician's office.  The patient was examined and prescribed AUGMENTIN.  A rapid strep test was negative and a complete blood count was normal.  The patient was examined again on 04-FEB-2009 and the symptoms were improved.  As of 05-FEB-2009, the patient was recovering.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/27/2009.  Follow-up information was received from the medical assistant.  It was reported that the 63 year old white male patient developed a viral syndrome including severe aphthous ulcers in the mouth not long after the vaccination OF zoster vaccine live (Oka/Merck).  The reporter stated that "there is no connection between the two".  At the time of the report, the patient recovered.  No further information is available.
Age: 1.23
Sex: M
Vaccine: VARCEL, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a medical assistant concerning a 14 month old patient who was vaccinated inadvertently with a dose of ZOSTAVAX (Oka/Merck) (lot #663194/1415X) and a dose of VARIVAX (lot # 662129/1752X) on the same day due to human error.  No adverse effect reported.  Follow-up information was received from the medical assistant.  It was reported that the 14 month old male child was suppose to received MMR II instead of ZOSTAVAX (Oka/Merck).  There was confusion between the 2 vaccines because both lids were red.  Follow-up information was received from the medical assistant.  It was reported that on 02-FEB-2008, the 15 month old male child with lactose intolerant and no illness at time of vaccination was vaccinated with a dose of ZOSTAVAX (lot # 663194/1415X) into the left thigh and the first dose of VARIVAX (lot # 662129/1752X) into the right thigh.  No symptoms reported.  No further information is available. This is in follow-up to report (s) previously submitted on 3/27/2009.  Follow-up information was received from the medical assistant.  It was reported that on 05-FEB-2008, the 15 month old male child with lactose intolerant was vaccinated with the first dose of ZOSTAVAX (Merck) (lot #663194/1415X) into the left thigh and was vaccinated SC with the first dose of VARIVAX (lot # 662129/1752X) into the right thigh.  No reactions reported.  No further information is available.
Sex: M
Vaccine: VARZOS
Symptoms: Oedema peripheral
Clinical narrative: Information has been received from a physician concerning a male who was vaccinated SQ with a 0.65 ml dose of ZOSTAVAX (Oka/Merck) at a pharmacy.  Subsequently the "patient's whole arm swelled up".  The patient sought unspecified medical attention. Follow-up information was received from the physician.  It was reported the patient was not administerd vaccine in the office.  The patient got the vaccine by a pharmacy and the patient's arm swelled up.  No further information is available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with ZOSTAVAX (Oka/Merck) 0.65ml (lot number, route and site not reported). After vaccination, the patient experienced shingles. This is one of several reports received from the same source. Additional information has been requested.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a registered pharmacist concerning a 74 year old male patient with no drug reactions/allergies, who on 04-FEB-2009 was vaccinated subcutaneously in the left arm with a 0.65 mL dose of ZOSTER vaccine live (Oka/Merck) (Lot # 662998/1620X).  There was no concomitant medication.  On 05-FEB-2009 the patient developed a rash on his right arm, chest and back after receiving ZOSTER vaccine live (Oka/Merck).  The patient was seen at an office.  There were no laboratory or diagnostic tests performed.  The patient was treated with PREDNISONE (unspecified) and the rash resolved.  On an unspecified date, the patient recovered.  Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a female patient who on an unspecified date was vaccinated with one dose of ZOSTAVAX (Oka/Merck). Two days after vaccination, the patient developed a varicella-like rash. The patient sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. No further information is available.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Hypersensitivity, Lip swelling, Pruritus, Tuberculin test
Clinical narrative: Information has been received from a registered pharmacist concerning a over 60 year old male with atrial fibrillation and a history of chickenpox and shingles and not known drugs allergies, who on 20-DEC-2008 was vaccinated with a 0.65 mL dose of ZOSTAVAX (Oka/Merck).  There was no concomitant medication.  After receiving the ZOSTAVAX (Oka/Merck) the patient had an allergic reaction.  Patient developed itchy red welts on the back of his arm and neck with lip swelling several hours after vaccination on 20-DEC-2008.  Initially he was treated with BENADRYL but lack of response caused the physician to give the patient MEDROL, ZYRTEC and ZANTAC.  Patient improved after taking MEDROL but still had an intermittent rash that had not resolved and changes location.  It had been on his buttocks and currently he had 3 small mildly itchy welts on his back.  Patient said the current rash was not "weepy and did not seem like his shingles rashes pre ZOSTAVAX (Oka/Merck).  The patient had a tuberculin skin test 30 days prior to received the dose of ZOSTAVAX (Oka/Merck).  The patient sought medical attention through an office visit.  At the time of this report the patient had not recovered.  Additional information has been requested.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: Information has been received from a registered pharmacist concerning a over 60 year old male with atrial fibrillation and a history of chickenpox and shingles and not known drugs allergies, who on 20-DEC-2008 was vaccinated with a 0.65 mL dose of ZOSTAVAX (Oka/Merck).  There was no concomitant medication.  After receiving the ZOSTAVAX (Oka/Merck) the patient had an allergic reaction.  Patient developed itchy red welts on the back of his arm and neck with lip swelling several hours after vaccination on 20-DEC-2008.  Initially he was treated with BENADRYL but lack of response caused the physician to give the patient MEDROL, ZYRTEC and ZANTAC.  Patient improved after taking MEDROL but still had an intermittent rash that had not resolved and changes location.  It had been on his buttocks and currently he had 3 small mildly itchy welts on his back.  Patient said the current rash was not "weepy and did not seem like his shingles rashes pre ZOSTAVAX (Oka/Merck).  The patient had a tuberculin skin test 30 days prior to received the dose of ZOSTAVAX (Oka/Merck).  The patient sought medical attention through an office visit.  At the time of this report the patient had not recovered.  Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Myalgia
Clinical narrative: Information has been received from a registered nurse concerning a 63 year old female who on 25-JUN-2008 was vaccinated SQ with a 0.65ml dose of ZOSTAVAX (Oka/Merck) (lot #: 659672/0294X). On approximately 25-JUN-2008, the patient experienced muscle aches and joint pain. The patient told the nurse that her symptoms began almost immediately after she received ZOSTAVAX (Oka/Merck), but the nurse did not know the actual date the symptoms began. The patient has seen more than one physician regarding her symptoms and mentioned she received a cortisone shot. At the time of this report, the patient was not recovered. Additional information has been requested.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a pharmacist concerning a 72 year old female with penicillin allergy who on 19-JAN-2009 was vaccinated with ZOSTAVAX (Oka/Merck) (lot number and site not reported) ).65 ml subcutaneous. Concomitant therapy included levothyroxine, hydrochlorothiazide (+) triamterene and ginkgo biloba. On approximately 2-FEB-2009, the patient developed a rash that came and went. At separate times the rash was located on the patient's torso and upper thighs. Additional information has been requested. Follow-up information was received from the pharmacist concerning the female patient who on 19-JAN-2009 was vaccinated with her first dose of ZOSTAVAX (Oka/merck) (lot number 662757/1622XX) into her deltoid. On an unspecified date the patient developed a miner rash. The outcome was unknown. There was no illness at time of vaccination. Additional information has been requested.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a medical assistant concerning a 77 year old female who on 03-FEB-2009 was vaccinated with ZOSTAVAX (Oka/Merck) (lot number, route and site not reported).  On approximately 07-FEB-2009, "over the weekend" the patient developed rash.  The patient was scheduled this week to see the physician.  Additional information has been requested.